David Markovitz

M.D. | Neurology


  7350 W College Dr, Suite 103, Palos Heights
     Illinois, 60463-1149
  708-361-3880    708-361-2187 Maps & Directions
David Markovitz is a Palos Heights, Illinois based neurologist who is specialized in Neurology. His current practice location is 7350 W College Dr, Suite 103, Palos Heights. Patients can reach him at 708-361-3880 or can fax him at 708-361-2187. David Markovitz is M.D. in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1316984172.
David Markovitz specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
David Markovitz speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: David Markovitz
Specialization: Neurology
Gender:Male
Credentials: M.D.
Practice Address:7350 W College Dr, Suite 103, Palos Heights,
Illinois, 60463-1149
Phone:708-361-3880
Fax:708-361-2187
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1316984172
NPI Enumeration Date: 01 Jun, 2006
NPI Last Update On: 10 Jun, 2013

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: David Markovitz
12100 S 80th Ave, #690
Palos Park, Illinois
Zip: 60464-0690
Phone Number: 708-361-3880
Fax Number: 708-361-2187
Patients can reach David Markovitz at 7350 W College Dr, Suite 103, Palos Heights, Illinois or can call to book an appointment on 708-361-3880.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.